Key result
Historical review highlights Jonas Salk's 1955 landmark publication on the first inactivated polio vaccine.
Why the study?
The significance and impact of the first inactivated poliomyelitis vaccine by Jonas Salk needed to be reconsidered in the context of its time and subsequent developments.
Answers are grounded in this paper and cite their sources.
It is difficult to look back at an important scientific contribution and to assess the full significance of the work. It must be evaluated in relation to the time in which it was written. What were its roots? What was the notable contribution of this work? Furthermore, where did it lead us? Only with that precious gift of knowing what really happened can we now look back and assess the broader significance of the contribution. Thus, we can examine the important article, "Considerations in the Preparation and Use of Poliomyelitis Vaccine," by Jonas Salk, published inThe Journalin August 1955.1 First Polio Vaccine In that year, there was an urgent problem, and this article represented one important response. Salk had been the first to take advantage of the basic contribution of Enders et al2in the propagation of poliovirus in non-neural tissue cultures and produced a formalininactivated
No takes yet. Share an insight, caveat, or question.
ER Alexander (1984) conducted a review in Poliomyelitis. Inactivated poliomyelitis vaccination was evaluated. This article provides a historical perspective on Jonas Salk's 1955 landmark publication regarding the preparation and use of the first formalin-inactivated poliomyelitis vaccine.
Synapse has enriched 10 related papers. Consider them for comparative context: